Shrestha Prazwal, Kaur Jasmine, Gupta Yeshdeep, Verma Hitesh
Department of Otorhinolaryngology-Head & Neck, All India Institute of Medical Sciences, 4065, 4th floor, Teaching block, New Delhi, India.
Department of Endocrinology, All India Institute of Medical Sciences, New Delhi, India.
Indian J Otolaryngol Head Neck Surg. 2022 Jun;74(2):212-216. doi: 10.1007/s12070-021-02938-6. Epub 2021 Oct 21.
Vitamin D is one of the thoroughly studied risk factors in the pathogenesis of allergic rhinitis (AR). Low serum level of vitamin D is well documented in the urban population of India. The supplementation policy of vitamin D is not uniform among practitioners. The study aims to assess the impact of vitamin D deficiency on AR & long-term quality of life in perennial AR patients with low vitamin D levels after its supplementation in the urban population. The policy for evaluation of serum level of vitamin D & its supplementation in deficit patients in AR is not uniform in our hospital. The data was extracted from the hospital records & the patients came to OPD in the year 2018-2019. Inclusion criteria were the clinical diagnosis (ARIA guideline) of the perennial form of AR where vitamin D assessment was performed before prescribing treatment & the patients received a complete course of vitamin D as per the recommendation followed in our Institute. The patients received oral antihistaminic & topical steroids based nasal spray and were clubbed together as a control group whereas, in the study group, the patients were pooled together who received vitamin D supplementation along with oral antihistaminic & topical steroids based nasal spray. Pre-treatment & post-treatment (at 8 weeks, 6 months, and 12 months) SNOT-22 scores were obtained from the records. The data were analyzed statistically using repeated measures ANOVA test. The study showed a significant decrease in the SNOT-22 score in both Groups in comparison to pre-treatment scores, but post-treatment group comparison was not found statistically significant at each point of comparison. The scores were found on the lower side in the study group at the initial two evaluation points whereas it was higher at the third point of evaluation. This study showed the additional therapeutic effect of vitamin D supplementation as an adjunct in the treatment of perennial AR patients but the effectiveness of the treatment does not last forever so maintenance therapy is required especially in areas following the Indian lifestyle.
维生素D是变应性鼻炎(AR)发病机制中研究充分的危险因素之一。印度城市人口中血清维生素D水平低已有充分记录。医生之间维生素D的补充政策并不统一。本研究旨在评估维生素D缺乏对城市地区维生素D水平低的常年性AR患者补充维生素D后AR及长期生活质量的影响。在我们医院,评估AR患者血清维生素D水平及其在缺乏患者中补充的政策并不统一。数据从医院记录中提取,患者于2018 - 2019年前来门诊。纳入标准为常年性AR的临床诊断(ARIA指南),在开治疗处方前进行维生素D评估,且患者按照我们研究所遵循的建议接受了完整疗程的维生素D治疗。患者接受口服抗组胺药和局部用类固醇鼻喷雾剂,并合并为对照组,而在研究组中,将接受维生素D补充剂以及口服抗组胺药和局部用类固醇鼻喷雾剂的患者合并在一起。从记录中获取治疗前及治疗后(8周、6个月和12个月)的SNOT - 22评分。使用重复测量方差分析对数据进行统计学分析。研究表明,与治疗前评分相比,两组的SNOT - 22评分均显著降低,但在每个比较点上治疗后组间比较未发现统计学差异。在最初两个评估点,研究组的评分较低,而在第三个评估点则较高。本研究表明,补充维生素D作为辅助治疗对常年性AR患者有额外的治疗效果,但治疗效果并非持久,因此需要维持治疗,尤其是在遵循印度生活方式的地区。